We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.39B
AUM Growth
+$344M
Cap. Flow
+$229M
Cap. Flow %
16.52%
Top 10 Hldgs %
16.24%
Holding
318
New
46
Increased
121
Reduced
103
Closed
19

Sector Composition

Rank Sector Weight
1 Industrials 19.51%
2 Technology 15.09%
3 Consumer Discretionary 11.18%
4 Healthcare 10.43%
5 Consumer Staples 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.A icon
276
Berkshire Hathaway Class A
BRK.A
$1.12T
$356K 0.03%
2
BMY icon
277
Bristol-Myers Squibb
BMY
$132B
$350K 0.03%
6,588
INFY icon
278
Infosys
INFY
$50.7B
$323K 0.02%
+45,600
New +$307K
LCII icon
279
LCI Industries
LCII
$2.65B
$323K 0.02%
+6,305
New +$321K
LPSN icon
280
LivePerson
LPSN
$32.3M
$311K 0.02%
+1,400
New +$232K
ABMD
281
DELISTED
Abiomed Inc
ABMD
$298K 0.02%
+11,145
New +$275K
A icon
282
Agilent Technologies
A
$41.2B
$288K 0.02%
7,035
WDFC icon
283
WD-40
WDFC
$3.15B
$276K 0.02%
+3,700
New +$264K
LOW icon
284
Lowe's Companies
LOW
$125B
$271K 0.02%
5,475
XEL icon
285
Xcel Energy
XEL
$48.8B
$245K 0.02%
8,765
-2,000
-19% -$56.5K
ARTX
286
DELISTED
Arotech Corporation
ARTX
$228K 0.02%
+65,196
New +$146K
BP icon
287
BP
BP
$107B
$224K 0.02%
+5,642
New +$210K
EWH icon
288
iShares MSCI Hong Kong ETF
EWH
$1.22B
$218K 0.02%
10,600
RMCF icon
289
Rocky Mountain Chocolate Factory
RMCF
$7.84M
$212K 0.02%
+18,258
New +$228K
GAP
290
The Gap Inc
GAP
$7.37B
$211K 0.02%
5,400
SMED
291
DELISTED
Sharps Compliance Corp
SMED
$209K 0.02%
44,101
+26,320
+148% +$112K
LLY icon
292
Eli Lilly
LLY
$1.06T
$207K 0.01%
4,050
HP icon
293
Helmerich & Payne
HP
$3.71B
$202K 0.01%
+2,400
New +$187K
STAB
294
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$184K 0.01%
7,862
+4,785
+156% +$130K
RRM
295
DELISTED
RR MEDIA LTD ORD SHS (ISR)
RRM
$171K 0.01%
+20,397
New +$159K
MDGL icon
296
Madrigal Pharmaceuticals
MDGL
$11.8B
$159K 0.01%
+869
New +$159K
PBT
297
Permian Basin Royalty Trust
PBT
$1.49B
$141K 0.01%
11,000
TRAK icon
298
ReposiTrak
TRAK
$159M
$134K 0.01%
+13,158
New +$125K
GVP
299
DELISTED
GSE Systems, Inc.
GVP
$19K ﹤0.01%
+1,208
New +$19.8K
ABG icon
300
Asbury Automotive
ABG
$3.85B
-42,387
Closed -$2.25M

Similar funds

Rice Hall James & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Rice Hall James & Associates held 318 positions worth $1.39B, up 33% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Rice Hall James & Associates deployed $229M of net new capital in Q4 2013, opening 46 new positions and adding to 121 existing holdings. Its largest new stake was Albany International: 427,571 shares worth $15.4M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Encompass Health, an estimated $3.94M trimmed.

  • Rice Hall James & Associates's largest Q4 2013 buy was Albany International: 427,571 shares worth $15.4M.
  • Rice Hall James & Associates added most to Integrated Device Technology I in Q4 2013, an estimated $10M increase.
  • Rice Hall James & Associates's biggest Q4 2013 reduction was Encompass Health, cutting an estimated $3.94M.
  • Rice Hall James & Associates fully exited Wendy's in Q4 2013, selling an estimated $12.3M.
  • Rice Hall James & Associates's ten largest holdings make up 16% of its $1.39B portfolio in Q4 2013.
  • Rice Hall James & Associates opened 46 new positions and closed 19 in Q4 2013.
  • Rice Hall James & Associates's portfolio value rose 33% quarter-over-quarter to $1.39B.

Based on Rice Hall James & Associates's 13F filing for Q4 2013, filed 11 Feb 2014.